CliffBio
small molecule

TESTOSTERONE

TESTOSTERONE

Loss of exclusivity—loss of exclusivity
CompanyAlembic →See this company's full patent-cliff portfolio

Drug detail

Brand nameTESTOSTERONE
Active ingredientTESTOSTERONE
Strength1.62% (20.25MG/1.25GM ACTUATION)
Dosage formGEL, METERED
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalMarch 2021
Marketing statusDISCN

More from Alembic

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.